BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

752 related articles for article (PubMed ID: 29658607)

  • 1. Key signaling pathways, genes and transcription factors associated with hepatocellular carcinoma.
    Wang J; Tian Y; Chen H; Li H; Zheng S
    Mol Med Rep; 2018 Jun; 17(6):8153-8160. PubMed ID: 29658607
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prediction and analysis of weighted genes in hepatocellular carcinoma using bioinformatics analysis.
    Zhang Q; Sun S; Zhu C; Zheng Y; Cai Q; Liang X; Xie H; Zhou J
    Mol Med Rep; 2019 Apr; 19(4):2479-2488. PubMed ID: 30720105
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of candidate biomarkers and pathways associated with SCLC by bioinformatics analysis.
    Wen P; Chidanguro T; Shi Z; Gu H; Wang N; Wang T; Li Y; Gao J
    Mol Med Rep; 2018 Aug; 18(2):1538-1550. PubMed ID: 29845250
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identifying hepatocellular carcinoma-related hub genes by bioinformatics analysis and CYP2C8 is a potential prognostic biomarker.
    Li C; Zhou D; Jiang X; Liu M; Tang H; Mei Z
    Gene; 2019 May; 698():9-18. PubMed ID: 30825595
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Screening Hub Genes as Prognostic Biomarkers of Hepatocellular Carcinoma by Bioinformatics Analysis.
    Zhou Z; Li Y; Hao H; Wang Y; Zhou Z; Wang Z; Chu X
    Cell Transplant; 2019 Dec; 28(1_suppl):76S-86S. PubMed ID: 31822116
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CDK1-PLK1/SGOL2/ANLN pathway mediating abnormal cell division in cell cycle may be a critical process in hepatocellular carcinoma.
    Li L; Huang K; Zhao H; Chen B; Ye Q; Yue J
    Cell Cycle; 2020 May; 19(10):1236-1252. PubMed ID: 32275843
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification and interaction analysis of key genes and microRNAs in hepatocellular carcinoma by bioinformatics analysis.
    Mou T; Zhu D; Wei X; Li T; Zheng D; Pu J; Guo Z; Wu Z
    World J Surg Oncol; 2017 Mar; 15(1):63. PubMed ID: 28302149
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The identification of key genes and pathways in hepatocellular carcinoma by bioinformatics analysis of high-throughput data.
    Zhang C; Peng L; Zhang Y; Liu Z; Li W; Chen S; Li G
    Med Oncol; 2017 Jun; 34(6):101. PubMed ID: 28432618
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular mechanisms of pathogenesis in hepatocellular carcinoma revealed by RNA‑sequencing.
    Liu Y; Yang Z; Du F; Yang Q; Hou J; Yan X; Geng Y; Zhao Y; Wang H
    Mol Med Rep; 2017 Nov; 16(5):6674-6682. PubMed ID: 28901494
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Screening and function analysis of hub genes and pathways in hepatocellular carcinoma via bioinformatics approaches.
    Zhang L; Huang Y; Ling J; Zhuo W; Yu Z; Shao M; Luo Y; Zhu Y
    Cancer Biomark; 2018; 22(3):511-521. PubMed ID: 29843214
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of core genes and outcomes in hepatocellular carcinoma by bioinformatics analysis.
    Shen S; Kong J; Qiu Y; Yang X; Wang W; Yan L
    J Cell Biochem; 2019 Jun; 120(6):10069-10081. PubMed ID: 30525236
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Screening key genes and signaling pathways in colorectal cancer by integrated bioinformatics analysis.
    Yu C; Chen F; Jiang J; Zhang H; Zhou M
    Mol Med Rep; 2019 Aug; 20(2):1259-1269. PubMed ID: 31173250
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bioinformatics analysis to identify the key genes affecting the progression and prognosis of hepatocellular carcinoma.
    Zhang Y; Wang S; Xiao J; Zhou H
    Biosci Rep; 2019 Feb; 39(2):. PubMed ID: 30705088
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Integrated bioinformatics analysis reveals key candidate genes and pathways in breast cancer.
    Wang Y; Zhang Y; Huang Q; Li C
    Mol Med Rep; 2018 Jun; 17(6):8091-8100. PubMed ID: 29693125
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bioinformatics analyses of significant genes, related pathways and candidate prognostic biomarkers in glioblastoma.
    Zhou L; Tang H; Wang F; Chen L; Ou S; Wu T; Xu J; Guo K
    Mol Med Rep; 2018 Nov; 18(5):4185-4196. PubMed ID: 30132538
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bioinformatics Analysis of Candidate Genes and Pathways Related to Hepatocellular Carcinoma in China: A Study Based on Public Databases.
    Zhang P; Feng J; Wu X; Chu W; Zhang Y; Li P
    Pathol Oncol Res; 2021; 27():588532. PubMed ID: 34257537
    [No Abstract]   [Full Text] [Related]  

  • 17. Identification of Key Pathways and Genes in Anaplastic Thyroid Carcinoma via Integrated Bioinformatics Analysis.
    Hu S; Liao Y; Chen L
    Med Sci Monit; 2018 Sep; 24():6438-6448. PubMed ID: 30213925
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bioinformatics analysis of key genes and pathways for hepatocellular carcinoma transformed from cirrhosis.
    He B; Yin J; Gong S; Gu J; Xiao J; Shi W; Ding W; He Y
    Medicine (Baltimore); 2017 Jun; 96(25):e6938. PubMed ID: 28640074
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overexpression of
    Bai L; Ren Y; Cui T
    J Comput Biol; 2020 Jun; 27(6):965-974. PubMed ID: 31593490
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bioinformatics analysis of gene expression alterations in microRNA‑122 knockout mice with hepatocellular carcinoma.
    He B; He Y; Shi W; Gong S; Chen X; Xiao J; Gu J; Ding W; Wang Y
    Mol Med Rep; 2017 Jun; 15(6):3681-3689. PubMed ID: 28393247
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 38.